Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Bullish on Planet Fitness with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Fitness app
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

According to analyst Christopher Carril from RBC Capital, Planet Fitness (NYSE: PLNT) continues to receive an Outperform rating with a revised price target of $80, up from $74. This change signifies a bullish perspective on the company’s future performance. Analysts have consistently shown confidence in Planet Fitness, with price targets ranging from $62 to $88 in the last year.

Planet Fitness Inc. (PLNT) Shows Positive Momentum in Stock Performance on March 5, 2024

On March 5, 2024, Planet Fitness Inc. (PLNT) showed positive momentum in its stock performance. According to data from CNN Money, PLNT is currently trading in the middle of its 52-week range and below its 200-day simple moving average.

The price of PLNT shares increased by $0.47 since the market last closed, representing a 0.76% rise. The stock opened at $62.50, which was $0.35 higher than its previous close. This indicates that there was strong buying interest in PLNT at the opening bell, pushing the stock price higher.

Despite trading below its 200-day moving average, the positive price momentum on March 5 suggests that investors are optimistic about the future prospects of Planet Fitness Inc.

Investors should continue to monitor PLNT’s performance in the coming days to see if the positive momentum continues. It is important to consider other factors such as market trends, company news, and economic indicators when making investment decisions. As always, it is recommended to conduct thorough research and consult with a financial advisor before making any investment decisions.

PLNT Stock Analysis: Steady Revenue Growth and Net Income Increase

On March 5, 2024, PLNT stock showed a steady performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $1.07 billion for the past year, with a significant increase of 14.36% compared to the previous year. However, the total revenue remained flat at $285.09 million for the last quarter.

Similarly, the net income for PLNT stood at $138.31 million for the past year, showing a notable increase of 39.15% from the previous year. The net income for the last quarter was reported at $35.34 million, remaining unchanged from the previous quarter.

Earnings per share (EPS) for PLNT were reported at $1.62 for the past year, reflecting a 38.1% increase from the previous year. The EPS for the last quarter was $0.41, holding steady compared to the previous quarter.

Overall, PLNT stock exhibited positive financial performance over the past year, with significant increases in total revenue, net income, and earnings per share. However, the stock’s performance remained flat in the last quarter, indicating a stable financial position for the company.

Investors and analysts may view PLNT stock as a reliable investment option based on its consistent growth in revenue and net income over the past year. The company’s ability to maintain its earnings per share despite flat revenue and net income in the last quarter could be seen as a positive sign for its future performance.

It is important for investors to conduct further research and analysis to make informed decisions about investing in PLNT stock, taking into consideration the company’s financial data and overall market conditions.

Tags: PLNT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances-and-tech

Analyst Reaffirms Buy Rating and 20 Price Target for The Marcus Corporation

ES stock news

Analyst Optimism Grows for NetApp as Citigroup Raises Price Target to 110

Electric Utilities Stock Exchange

The York Water Reports Strong Fourth Quarter Financial Results for 2023

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com